hardcover. Condizione: Very Good. Pages are clean with no markings.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 139,30
Quantità: 8 disponibili
Aggiungi al carrelloCondizione: new.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 148,43
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 148,42
Quantità: 8 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 179,53
Quantità: 4 disponibili
Aggiungi al carrelloHardback. Condizione: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
EUR 173,08
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 336.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 165,57
Quantità: 8 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Chiron Media, Wallingford, Regno Unito
EUR 169,29
Quantità: 8 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
EUR 183,93
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 616.
EUR 164,26
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Condizione: New. pp. 336.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 169,26
Quantità: 8 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
EUR 188,58
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . .
Condizione: New. pp. 616.
EUR 161,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Jianling Wang is the Cambridge Head of Discovery ADME at Novartis Institutes for BioMedical Research. He has published over 40 journal papers, reviews, and book chapters and lectured at over 30 scientific conferences and courses. Laszlo Urban is the Executi.
Da: Revaluation Books, Exeter, Regno Unito
EUR 219,36
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock.
EUR 236,37
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Da: Rarewaves.com UK, London, Regno Unito
EUR 170,10
Quantità: 4 disponibili
Aggiungi al carrelloHardback. Condizione: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 200,66
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward.The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Lingua: Inglese
Editore: John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Prima edizione Print on Demand
Hardcover. Condizione: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 176,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 1029.
Lingua: Inglese
Editore: John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Da: CitiRetail, Stevenage, Regno Unito
Prima edizione Print on Demand
EUR 160,08
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Da: Revaluation Books, Exeter, Regno Unito
EUR 199,43
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock. This item is printed on demand.
Lingua: Inglese
Editore: John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Da: AussieBookSeller, Truganina, VIC, Australia
Prima edizione Print on Demand
EUR 234,86
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.